ZA200408372B - Use of topical compositions for the control of microbial diseases of the nail - Google Patents
Use of topical compositions for the control of microbial diseases of the nail Download PDFInfo
- Publication number
- ZA200408372B ZA200408372B ZA200408372A ZA200408372A ZA200408372B ZA 200408372 B ZA200408372 B ZA 200408372B ZA 200408372 A ZA200408372 A ZA 200408372A ZA 200408372 A ZA200408372 A ZA 200408372A ZA 200408372 B ZA200408372 B ZA 200408372B
- Authority
- ZA
- South Africa
- Prior art keywords
- nail
- medicament
- copper
- use according
- onychomycosis
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 30
- 230000000813 microbial effect Effects 0.000 title claims description 18
- 201000010099 disease Diseases 0.000 title claims description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims description 13
- 230000000699 topical effect Effects 0.000 title claims description 10
- ZZBBCSFCMKWYQR-UHFFFAOYSA-N copper;dioxido(oxo)silane Chemical compound [Cu+2].[O-][Si]([O-])=O ZZBBCSFCMKWYQR-UHFFFAOYSA-N 0.000 claims description 48
- 238000000034 method Methods 0.000 claims description 46
- 208000015181 infectious disease Diseases 0.000 claims description 28
- 208000010195 Onychomycosis Diseases 0.000 claims description 27
- 201000005882 tinea unguium Diseases 0.000 claims description 27
- 239000010949 copper Substances 0.000 claims description 19
- 239000003814 drug Substances 0.000 claims description 15
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 12
- 229910052802 copper Inorganic materials 0.000 claims description 12
- 241001480043 Arthrodermataceae Species 0.000 claims description 10
- 241000223229 Trichophyton rubrum Species 0.000 claims description 10
- 239000006071 cream Substances 0.000 claims description 10
- 230000037304 dermatophytes Effects 0.000 claims description 10
- 241001045770 Trichophyton mentagrophytes Species 0.000 claims description 8
- 238000011200 topical administration Methods 0.000 claims description 8
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 6
- 241000222122 Candida albicans Species 0.000 claims description 6
- 241000223238 Trichophyton Species 0.000 claims description 6
- 230000000845 anti-microbial effect Effects 0.000 claims description 6
- 241001480048 Trichophyton tonsurans Species 0.000 claims description 5
- 239000004599 antimicrobial Substances 0.000 claims description 5
- 229940095731 candida albicans Drugs 0.000 claims description 5
- 241001480036 Epidermophyton floccosum Species 0.000 claims description 4
- 241000555676 Malassezia Species 0.000 claims description 4
- 241000555688 Malassezia furfur Species 0.000 claims description 4
- 241000893980 Microsporum canis Species 0.000 claims description 4
- 241000893976 Nannizzia gypsea Species 0.000 claims description 4
- 241001480046 Trichophyton schoenleinii Species 0.000 claims description 4
- 241000894007 species Species 0.000 claims description 4
- 241001019659 Acremonium <Plectosphaerellaceae> Species 0.000 claims description 3
- 241000228212 Aspergillus Species 0.000 claims description 3
- 241001480035 Epidermophyton Species 0.000 claims description 3
- 241001291478 Malassezia sympodialis Species 0.000 claims description 3
- 241001480037 Microsporum Species 0.000 claims description 3
- 241000178274 Trichomonascus ciferrii Species 0.000 claims description 3
- 241000222126 [Candida] glabrata Species 0.000 claims description 3
- 208000032343 candida glabrata infection Diseases 0.000 claims description 3
- 206010034016 Paronychia Diseases 0.000 claims description 2
- 206010061304 Nail infection Diseases 0.000 claims 1
- 210000000282 nail Anatomy 0.000 description 72
- 239000000243 solution Substances 0.000 description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- 208000031888 Mycoses Diseases 0.000 description 13
- 238000003756 stirring Methods 0.000 description 12
- 239000012071 phase Substances 0.000 description 11
- 208000007163 Dermatomycoses Diseases 0.000 description 7
- 206010017533 Fungal infection Diseases 0.000 description 6
- 239000004115 Sodium Silicate Substances 0.000 description 6
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 description 6
- 230000000855 fungicidal effect Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 6
- 229910052911 sodium silicate Inorganic materials 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000003860 topical agent Substances 0.000 description 5
- 241000233866 Fungi Species 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 229940121375 antifungal agent Drugs 0.000 description 3
- 239000003429 antifungal agent Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000003349 gelling agent Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 206010067482 No adverse event Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229960003749 ciclopirox Drugs 0.000 description 2
- SCKYRAXSEDYPSA-UHFFFAOYSA-N ciclopirox Chemical group ON1C(=O)C=C(C)C=C1C1CCCCC1 SCKYRAXSEDYPSA-UHFFFAOYSA-N 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 210000004904 fingernail bed Anatomy 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 239000000346 nonvolatile oil Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 210000004906 toe nail Anatomy 0.000 description 2
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 description 1
- VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 description 1
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- 241000589291 Acinetobacter Species 0.000 description 1
- 241000228197 Aspergillus flavus Species 0.000 description 1
- 241001225321 Aspergillus fumigatus Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000222178 Candida tropicalis Species 0.000 description 1
- 241000588919 Citrobacter freundii Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 101100348017 Drosophila melanogaster Nazo gene Proteins 0.000 description 1
- 239000004150 EU approved colour Substances 0.000 description 1
- 241000588697 Enterobacter cloacae Species 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 241000587112 Enterobacteriaceae sp. Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000194031 Enterococcus faecium Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 241000588749 Klebsiella oxytoca Species 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 244000285963 Kluyveromyces fragilis Species 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
- 241000588655 Moraxella catarrhalis Species 0.000 description 1
- 241000588772 Morganella morganii Species 0.000 description 1
- 241000235645 Pichia kudriavzevii Species 0.000 description 1
- 241000588770 Proteus mirabilis Species 0.000 description 1
- 241000588768 Providencia Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000132889 Scedosporium Species 0.000 description 1
- 241000122799 Scopulariopsis Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241001147691 Staphylococcus saprophyticus Species 0.000 description 1
- 241000122973 Stenotrophomonas maltophilia Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000730665 Streptococcus pneumoniae 27 Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 229940031955 anhydrous lanolin Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000012871 anti-fungal composition Substances 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003683 cardiac damage Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229940056318 ceteth-20 Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000037765 diseases and disorders Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229960003913 econazole Drugs 0.000 description 1
- 229940092559 enterobacter aerogenes Drugs 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 229960004884 fluconazole Drugs 0.000 description 1
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 210000000003 hoof Anatomy 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229960004130 itraconazole Drugs 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229960002509 miconazole Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229940076266 morganella morganii Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- OZGNYLLQHRPOBR-DHZHZOJOSA-N naftifine Chemical compound C=1C=CC2=CC=CC=C2C=1CN(C)C\C=C\C1=CC=CC=C1 OZGNYLLQHRPOBR-DHZHZOJOSA-N 0.000 description 1
- 229960004313 naftifine Drugs 0.000 description 1
- 208000026721 nail disease Diseases 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 229940006093 opthalmologic coloring agent diagnostic Drugs 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 229960003483 oxiconazole Drugs 0.000 description 1
- QRJJEGAJXVEBNE-MOHJPFBDSA-N oxiconazole Chemical compound ClC1=CC(Cl)=CC=C1CO\N=C(C=1C(=CC(Cl)=CC=1)Cl)\CN1C=NC=C1 QRJJEGAJXVEBNE-MOHJPFBDSA-N 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- -1 patches Chemical compound 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229940055019 propionibacterium acne Drugs 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 1
- 229960002722 terbinafine Drugs 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPS1793A AUPS179302A0 (en) | 2002-04-17 | 2002-04-17 | Use of topical compositions for the control of microbial diseases of the nail |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200408372B true ZA200408372B (en) | 2007-10-31 |
Family
ID=3835370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200408372A ZA200408372B (en) | 2002-04-17 | 2003-04-17 | Use of topical compositions for the control of microbial diseases of the nail |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1494688A4 (https=) |
| JP (1) | JP2005523317A (https=) |
| CN (1) | CN1649605A (https=) |
| AP (1) | AP1777A (https=) |
| AU (2) | AUPS179302A0 (https=) |
| BR (1) | BR0309266A (https=) |
| CA (1) | CA2482439A1 (https=) |
| EA (1) | EA200401395A1 (https=) |
| HK (1) | HK1079983A1 (https=) |
| IL (1) | IL164557A0 (https=) |
| MX (1) | MXPA04010131A (https=) |
| NZ (1) | NZ535903A (https=) |
| OA (1) | OA12808A (https=) |
| WO (1) | WO2003088983A1 (https=) |
| ZA (1) | ZA200408372B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070116745A1 (en) * | 2004-02-16 | 2007-05-24 | Conve Ltd. | Spermicidal preparations and uses thereof |
| CA2587029C (en) * | 2004-11-07 | 2013-09-10 | The Cupron Corporation | Methods and materials for treating wounds, burns, and skin conditions |
| KR101254818B1 (ko) | 2004-11-09 | 2013-04-15 | 쿠프론 인코포레이티드 | 피부 보호 방법 및 물질 |
| CN101115475A (zh) * | 2004-12-10 | 2008-01-30 | 塔利马治疗公司 | 用于治疗指甲单位病症的组合物和方法 |
| WO2006096937A1 (en) * | 2005-03-16 | 2006-09-21 | Conve Ltd | Use of copper silicate for the control of herpes infections |
| CN118634190B (zh) * | 2024-08-12 | 2024-11-22 | 上海方予健康医药科技有限公司 | 一种三唑类药物混悬液及其制备方法和用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL173260B (nl) * | 1970-07-23 | 1983-08-01 | Degussa | Werkwijze voor het bereiden van kopersilicaten. |
| SG47493A1 (en) * | 1991-10-17 | 1998-04-17 | Sheen Biotechnology Pty Ltd | Pesticide and fungicide |
| AUPP068497A0 (en) * | 1997-12-02 | 1998-01-08 | Sheen Biotechnology Pty Ltd | Use of copper for the control of legionella |
| CA2431651A1 (en) * | 2000-11-16 | 2002-05-23 | Kenneth T. Zeiler | Antifungal nail composition and method of use |
-
2002
- 2002-04-17 AU AUPS1793A patent/AUPS179302A0/en not_active Abandoned
-
2003
- 2003-04-17 OA OA1200400283A patent/OA12808A/en unknown
- 2003-04-17 CA CA002482439A patent/CA2482439A1/en not_active Abandoned
- 2003-04-17 NZ NZ535903A patent/NZ535903A/en unknown
- 2003-04-17 BR BR0309266-6A patent/BR0309266A/pt not_active IP Right Cessation
- 2003-04-17 AU AU2003227095A patent/AU2003227095B2/en not_active Ceased
- 2003-04-17 ZA ZA200408372A patent/ZA200408372B/en unknown
- 2003-04-17 MX MXPA04010131A patent/MXPA04010131A/es unknown
- 2003-04-17 EA EA200401395A patent/EA200401395A1/ru unknown
- 2003-04-17 EP EP03746769A patent/EP1494688A4/en not_active Withdrawn
- 2003-04-17 AP APAP/P/2004/003163A patent/AP1777A/en active
- 2003-04-17 HK HK06100021.7A patent/HK1079983A1/zh unknown
- 2003-04-17 CN CNA03809987XA patent/CN1649605A/zh active Pending
- 2003-04-17 WO PCT/AU2003/000471 patent/WO2003088983A1/en not_active Ceased
- 2003-04-17 JP JP2003585735A patent/JP2005523317A/ja active Pending
-
2004
- 2004-10-13 IL IL16455704A patent/IL164557A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003088983A1 (en) | 2003-10-30 |
| OA12808A (en) | 2006-07-11 |
| EP1494688A1 (en) | 2005-01-12 |
| HK1079983A1 (zh) | 2006-04-21 |
| AU2003227095B2 (en) | 2007-05-31 |
| JP2005523317A (ja) | 2005-08-04 |
| MXPA04010131A (es) | 2005-06-08 |
| BR0309266A (pt) | 2005-03-01 |
| AP2004003163A0 (en) | 2004-12-31 |
| AUPS179302A0 (en) | 2002-05-30 |
| EP1494688A4 (en) | 2007-07-04 |
| IL164557A0 (en) | 2005-12-18 |
| CA2482439A1 (en) | 2003-10-30 |
| AP1777A (en) | 2007-09-03 |
| EA200401395A1 (ru) | 2005-06-30 |
| CN1649605A (zh) | 2005-08-03 |
| NZ535903A (en) | 2005-06-24 |
| AU2003227095A1 (en) | 2003-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5661170A (en) | Antimicrobial compositions and methods for using the same | |
| US9084821B2 (en) | Transdermal compositions | |
| JP3777499B2 (ja) | 抗真菌組成物 | |
| US9962347B2 (en) | Broad spectrum pharmacological composition for treatment of various infections and diseases and methods of use | |
| CA1050548A (en) | Zinc sulfadiazine as a medicament | |
| CN85109101A (zh) | 抗菌膏的制备方法 | |
| JPH0214327B2 (https=) | ||
| DK165440B (da) | Farmaceutiske praeparater til topisk anvendelse indeholdende propylenglycol og/eller polyethylenglycol og urinstof som aktive hovedbestanddele | |
| JP6941329B1 (ja) | 復方マルボフロキサシンスプレー及び製造方法 | |
| US20230247991A1 (en) | Antimicrobial mixture containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one and an organic acid compound, and cosmetic composition containing same | |
| JP2002363101A (ja) | 外用剤 | |
| AU2003227095B2 (en) | Use of topical compositions for the control of microbial diseases of the nail | |
| CA2322994A1 (en) | Topical antiseptic compositions and methods | |
| AU2016233317A1 (en) | Treatment of acne vulgaris with sequential topical formulations comprising antimicrobial organic acid anions in alkaline phase | |
| JP3899267B2 (ja) | 皮膚、粘膜、器官または組織の疾患を治療するためのトシルクロルアミドの使用 | |
| US20050100561A1 (en) | Use of topical compositions for the control of microbial diseases of the nail | |
| JPH032872B2 (https=) | ||
| JP3793596B2 (ja) | 抗真菌性外用組成物 | |
| WO2014045961A1 (ja) | 皮膚真菌症治療剤 | |
| JP2006501223A (ja) | 真菌感染を治療する方法 | |
| RU2563811C1 (ru) | Фармацевтическая композиция для лечения грибковых заболеваний | |
| JP2002505257A (ja) | ベンゾイルフェニル尿素を含む殺菌剤組成物 | |
| RU2238092C2 (ru) | Водная лекарственная композиция для лечения заболеваний кожи | |
| US20230190792A1 (en) | Topical preparations | |
| JP4875813B2 (ja) | 抗真菌組成物 |